Company intelligence / Profile preview

ChemChina

Beijing, Beijing, China

Ownership: Private
Employees: ~148000
Development stage: Other

Overview

ChemChina is a global chemicals leader with strong commercial success in agrochemicals, crop protection, animal nutrition, and industrial chemicals. Clinical drug development is not core; rather, its relevance is through acquired subsidiaries engaged in biotech, animal health, and crop science. Syngenta’s biotech research center in Beijing enhances its life sciences portfolio.

Therapeutic areas: Other
Modalities: Small moleculeBiologic
Industry: Agriculture & AgTech

Partnerships

BlackstoneGlobal R&D alliances through Syngenta and Adisseo

Beyond the preview

Go deeper on ChemChina.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ChemChina.

Explore the full profile